Total Funding
1
Total FundingGrant raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3530996
DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company,
John H. Streiff: Chief Chemoinformatics Officer
About the Company
DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company, located in Birmingham, AL, formed with the ultimate goal of integrating human cell physiology with the drug discovery critical path. DBM’s founder, Erik Schwiebert, Ph.D., a physiologist by trade, launched the company in October 2007 and closed on seed capital investment with
Greer Capital Advisors in November of 2007 (Birmingham Technology Fund). Since then DBM has continued to grow and gain recognition both locally and nationally.
